Halozyme Therapeutics, Inc.HALONASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank0
3Y CAGR-21.2%
5Y CAGR-23.3%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-21.2%/yr
vs -3.9%/yr prior
5Y CAGR
-23.3%/yr
Consistent
Acceleration
-17.3pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 5.77 | -3.3% |
| 2024 | 5.97 | +1.6% |
| 2023 | 5.88 | -50.2% |
| 2022 | 11.80 | -7.5% |
| 2021 | 12.76 | -41.3% |
| 2020 | 21.74 | +66.5% |
| 2019 | 13.06 | -5.5% |
| 2018 | 13.82 | +58.3% |
| 2017 | 8.73 | +1.9% |
| 2016 | 8.57 | - |